Patents Assigned to PFICKER PHARMACEUTICALS LTD.
  • Publication number: 20100015115
    Abstract: The present invention discloses a compound preparation for quickly reducing oxidative stress, which contains small molecules and mineral trace elements that can remove or help removing free radicals, can regulate the function of endocrine and circulatory digestive system, as well as other components that can rebuild inner harmony. The compound preparation is in solid dosage form, preferably effervescent tablet or effervescent granules. The preparative method of the compound preparation is also disclosed. Animal experiment and clinical trial show that the invention has strong effect in reducing oxidative stress and disease prevention.
    Type: Application
    Filed: April 23, 2007
    Publication date: January 21, 2010
    Applicant: Sino-US PFICKER PHARMACEUTICALS LTD.
    Inventors: Hongping Yie, Meg M. Sun, Zuolin Zhu, Wei Sun, Zhongquan Zhao, Jinyuan Wang, Feng Zheng
  • Publication number: 20090196910
    Abstract: A preparation of statins for prolonged release. The preparation is a transdermal therapeutic system or hypodermic implantation system. And they overcome the problem of low bioavailability and increase patient compliance. The statins in the invention contain all of statins and responding salts, hydroxyl ester derivatives at 4-position. The invention has many advantages: for example, reduce dosage frequency, remain stable and lasting blood concentration of medicine, further improve the curative effect, provide patients with a convenient and safety means of administration, and obtain an effective period of up to seven days to months by taking medicine once.
    Type: Application
    Filed: November 21, 2005
    Publication date: August 6, 2009
    Applicant: PFICKER PHARMACEUTICALS LTD.
    Inventors: Hongping Yie, Zuolin Zhu, Meg M. Sun
  • Publication number: 20090043115
    Abstract: The present invention discloses a process for producing Simvastatin and intermediate thereof. The present invention uses inexpensive and easily available reagents, its condition is mild, and it leaves out the protective and deprotective steps, which are necessary in prior methods. Compared with prior art, the esterifying condition in 8-position is greatly simplified.
    Type: Application
    Filed: September 26, 2005
    Publication date: February 12, 2009
    Applicant: PFICKER PHARMACEUTICALS LTD.
    Inventors: Hongping Ye, Meg M. Sun, Zuolin Zhu
  • Publication number: 20080268066
    Abstract: The present invention discloses a composition preparation for preventing and treating diabetes, which mainly contains oral hypoglycemic agents, Vitamin E, chromic pyridine formate, selenium, lutein, folic acid, Vitamin C, alpha_lipoic acid, lycopene, nicotinamide, coenzyme Q10, and vitamin complexes and mineral. The medicament of the invention can decrease oxidative stress in vivo, promote body immunity, repair the critical organs in vivo such as pancreas, by supplying the mineral, vitamins and other substances which are insufficient in the patient suffering from diabetes, to prevent and treat diabetes.
    Type: Application
    Filed: September 23, 2005
    Publication date: October 30, 2008
    Applicant: PFICKER PHARMACEUTICALS LTD.
    Inventors: Hongping Yie, Zuolin Zhu, Meg M. Sun
  • Publication number: 20080160001
    Abstract: The present disclosure provides a combined medicament for reducing blood fat with safety and high efficiency, the active ingredients of which include an agent for lowering blood fat such as statins; an agent for protecting and repairing liver such as silymarin; an agent for protecting kidney, heart, blood vessel or muscle such as coenzyme Q10 and various excipients desired for producing medicaments. The present disclosure can safely and reliably lower the concentration of cholesterol in the blood; protect blood vessels of heart and brain and provide them with nutrition; protect and repair other relevant causes of disease which result in the increasing of blood fat; and lower, even eliminate the side effects of the damage of statins on muscle and liver.
    Type: Application
    Filed: March 28, 2005
    Publication date: July 3, 2008
    Applicant: PFICKER PHARMACEUTICALS LTD.
    Inventors: Hongping Ye, Zuolin Zhu, Meg M. Sun